MAGLi 432 is a potent, highly selective, non-covalent, reversible (MAGL) inhibitor that binds with high affinity to the MAGL active site, with IC50 values of 4.2 nM (human enzyme) and 3.1 nM (mouse enzyme), MAGLi 432 can be used to study neurological disorders such as chronic inflammation, multiple sclerosis, blood-brain barrier dysfunction, Alzheimers disease and Parkinsons disease.
Molecular Weight:
463.8
CAS Number:
[2361575-20-2]
Formula:
C22H24BrClN2O2
Target:
Others|||MAGL
T62937
* VAT and and shipping costs not included. Errors and price changes excepted
